Finance

Beta
Lists
APRE:NASDAQ
Aprea Therapeutics Inc
$0.79
+0.04%
(+0.00030) 1D
Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APRE...
Open
$0.75
High
$0.79
Low
$0.72
Mkt. cap
9.78M
Avg. vol.
139.33K
Volume
0.00
52-wk high
$2.22
52-wk low
$0.55
EPS
-$1.54
Beta
1.51
Shares outstanding
12.38M
No. of employees
8
Open
$0.75
High
$0.79
Low
$0.72
Mkt. cap
9.78M
Avg. vol.
139.33K
Volume
0.00
52-wk high
$2.22
52-wk low
$0.55
EPS
-$1.54
Beta
1.51
Shares outstanding
12.38M
No. of employees
8
News stories
From sources across the web
About Aprea Therapeutics Inc
CEO-
Employees8
Founded-
Headquarters-
SectorBiotechnology
Websiteaprea.com
Analyst ratings
Based on 4 analysts giving stock ratings to APRE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for APRE in the last 3 months.
Highest
Current $0.79
$6.00 (+659.49%)
Average
$4.30 (+444.30%)
Lowest
$1.20 (+51.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jay Olson
Oppenheimer
Buy
Initiated
$5.00
+532.9%
06/15/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$1.20
+51.9%
06/01/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
$5.00
+532.9%
05/13/2026
Robert Driscoll
Wedbush
Buy
Reiterated
$6.00
+659.5%
05/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
118.11K
1.85K
3.34K
-
Cost of goods sold
1.91M
1.64M
1.01M
1.61M
Cost of revenue
1.91M
1.64M
1.01M
1.61M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.59M
1.48M
1.64M
1.82M
Operating expense
1.59M
1.48M
1.64M
1.82M
Total operating expenses
3.51M
3.12M
2.65M
3.43M
Operating income
-3.39M
-3.12M
-2.64M
-3.43M
Other non operating income
-
-
77.50K
-
EBT including unusual items
-3.24M
-2.97M
-2.46M
-3.29M
EBT excluding unusual items
-3.24M
-2.97M
-2.46M
-3.29M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.24M
-2.97M
-2.46M
-3.29M
Net profit margin
-2,742.23%
-160,844.70%
-73,587.95%
-
Earnings per share
-0.53
-0.47
-0.32
-0.22
Interest and investment income
178.03K
150.67K
118.66K
134.78K
Interest expense
-
-
-
-
Net interest expenses
178.03K
150.67K
118.66K
134.78K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.38M
-3.11M
-2.64M
-3.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of APRE
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer